Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats

Archives of Medical Science

Volumn 11, Issue 5, 2015, Pages 1119-1128

  Kertmen, Hayri ^a   Gürer, Bora ^a   Yilmaz, Erdal Resit ^a   Kanat, Mehmet Ali ^b   Arikok, Ata Türker ^a   Ergüder, Berrin Imge ^c   Hasturk, Askin Esen ^b   Ergil, Julide ^a   Sekerci, Zeki ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Antiapoptosis; Antioxidation; Darbepoetin ; Methylprednisolone; Neuroprotection; Rat; Traumatic brain injury

Indexed keywords

CASPASE 3; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHYLPREDNISOLONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SKIN INCISION; TISSUE LEVEL; TRAUMATIC BRAIN INJURY;

EID: 84944029393     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2015.54869     Document Type: Article

References (78)

1. Siesjö BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med 1993; 22: 959-69.
2. Marshall LF. Head injury: Recent past, present, and future. Neurosurgery 2000; 47: 546-61.
3. Yurdakoc A, Gunday I, Memis D. Effects of halothane, isoflurane, and sevoflurane on lipid peroxidation following experimental closed head trauma in rats. Acta Anaesthesiol Scand 2008; 52: 658-63.
4. Hall ED, Braughler JM. Central nervous system trauma and stroke. II. Physiological and pharmacological evi dence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 1989; 6: 303-13.
5. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: The role of oxygen free radicals. Neurosurgery 1990; 27: 1-11.
6. Awasthi D, Church DF, Torbati D, Carey ME, Pryor WA. Oxidative stress following traumatic brain injury in rats. Surg Neurol 1997; 47: 575-81.
7. Lotocki G, Alonso OF, Frydel B, Dietrich WD, Keane RW. Monoubiquitination and cellular distribution of XIAP in neurons after traumatic brain injury. J Cereb Blood Flow Metab 2003; 23: 1129-36.
8. Wennersten A, Holmin S, Mathiesen T. Characterization of Bax and Bcl-2 in apoptosis after experimental traumatic brain injury in the rat. Acta Neuropathol 2003; 105: 281-8.
9. Krantz SB. Erythropoietin. Blood 1991; 77: 419-34.
10. Markham A, Bryson HM. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeuticuse in nonrenal applications. Drugs 1995; 49: 232-54.
11. Celik M, Gökmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A 2002; 99: 2258-63.
12. Gorio A, Gokmen N, Erbayraktar S, et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002; 99: 9450-5.
13. Grasso G, Sfacteria A, Erbayraktar S, et al. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine 2006; 4: 310-8.
14. Grasso G, Graziano F, Sfacteria A, et al. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery 2009; 65: 763-9.
15. Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 2001; 45: 7-14.
16. Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 2002; 135: 823-9.
17. Cherian L, Goodman JC, Robertson C. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther 2007; 322: 789-94.
18. Brines M, Grasso G, Fiordaliso F, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004; 101: 14907-12.
19. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 2000; 59: 419-25.
20. Egrie JC, Browne JK. Development and characterization of darbepoetin alfa. Oncology (Williston Park) 2002; 16: 13-22.
21. Yilmaz ER, Kertmen H, Dolgun H, et al. Effects of darbepoetin- alpha in spinal cord ischemia-reperfusion injury in the rabbit. Acta Neurochir (Wien) 2012; 154: 1037-44.
22. Yilmaz ER, Kertmen H, Gürer B, et al. The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats. Acta Neurochir (Wien) 2013; 155: 141-9.
23. Liu D, Shan Y, Valluru L, Bao F. Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: Comparison with methylprednisolone. BMC Neurosci 2013; 14: 23.
24. Chang CM, Lee MH, Wang TC, Weng HH, Chung CY, Yang JT. Brain protection by methylprednisolone in rats with spinal cord injury. Neuroreport 2009; 20: 968-72.
25. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 1994; 80: 291-300.
26. Ucar T, Tanriover G, Gurer I, Onal MZ, Kazan S. Modified experimental mild traumatic brain injury model. J Trauma 2006; 60: 558-65.
27. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
28. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
29. Durak I, Kavutcu M, Kaçmaz M, et al. Effects of isoflurane on nitric oxide metabolism and oxidant status of rat myocardium. Acta Anaesthesiol Scand 2001; 45: 119-22.
30. Prajda N, Weber G. Malignant transformation-linked imbalance: Decreased XO activity in hepatomas. FEBS Lett 1975; 59: 245-9.
31. Lukacova N, Halat G, Chavko M, Marsala J. Ischemia-reperfusion injury in the spinal cord of rabbits strongly enhances lipid peroxidation and modifies phospholipid profiles. Neurochem Res 1996; 21: 869-73.
32. Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988; 63: 390-408.
33. Ates O, Cayli S, Altinoz E, et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 2007; 294: 137-44.
34. Kontos HA, Povlishock JT. Oxygen radicals in brain injury. Cent Nerv Syst Trauma 1986; 3: 257-63.
35. Nishio S, Yunoki M, Noguchi Y, Kawauchi M, Asari S, Ohmoto T. Detection of lipid peroxidation and hydroxyl radicals in brain contusion of rats. Acta Neurochir Suppl 1997; 70: 84-6.
36. Pineda JA, Wang KK, Hayes RL. Biomarkers of proteolytic damage following traumatic brain injury. Brain Pathol 200; 14: 202-9.
37. Lappin T. The cellular biology of erythropoietin receptors. Oncologist 2003; 8: 15-8.
38. Wright GL, Hanlon P, Amin K, Steenberger C, Murphy E, Arcasoy MO. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 2004; 18: 1031-3.
39. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C. Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 2005; 75: 1100-5.
40. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: Effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004; 27: 113-20.
41. Marti HH, Bernaudin M, Petit E, Bauer C. Neuroprotection and angiogenesis: Dual role of erythropoietin in brain ischemia. News Physiol Sci 2000; 15: 225-9.
42. Sadamoto Y, Igase K, Sakanaka M, et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 1998; 253: 26-32.
43. Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95: 4635-40.
44. Sirén AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-9.
45. Banks WA, Jumbe NL, Farrell CL, Niehoff ML, Heatherington AC. Passage of erythropoietic agents across the blood-brain barrier: A comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol 2004; 505: 93-101.
46. Belayev L, Khoutorova L, Zhao W, et al. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke 2005; 36: 1071-6.
47. Yang WS, Chang JW, Han NJ, Park SK. Darbepoetin alfa suppresses tumor necrosis factor-alpha-induced endothelin- 1 production through antioxidant action in human aortic endothelial cells: Role of sialic acid residues. Free Radic Biol Med 2011; 50: 1242-51.
48. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 2001; 16: 3-13.
49. Iijima R, Takahashi H, Namme R, Ikegami S, Yamazaki M. Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Lett 2004; 561: 163-6.
50. d'Uscio LV, Smith LA, Katusic ZS. Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase. Hypertension 2010; 55: 998-1004.
51. Katavetin P, Inagi R, Miyata T, et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007; 359: 928-34.
52. Elliott S, Pham E, Macdougall IC. Erythropoietins: A common mechanism of action. Exp Hematol 2008; 36: 1573-84.
53. Cassis P, Azzollini N, Solini S, et al. Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Transplantation 2011; 92: 271-9.
54. Akcora B, Altug ME, Kontas T, Atik E. The protective effect of darbepoetin alfa on experimental testicular torsion and detorsion injury. Int J Urol 2007; 14: 846-50.
55. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. Oxidative stress in closed-head injury: Brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 1997; 17: 1007-19.
56. Tyurin VA, Tyurina YY, Borisenko GG, et al. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J Neurochem 2000; 75: 2178-89.
57. Ozdemir D, Uysal N, Gonenc S, et al. Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res 2005; 54: 631-7.
58. Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull 1993; 49: 577-87.
59. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 2004; 36: 1-9.
60. Schaller BJ. The role of endothelin in stroke: Experimental data and underlying pathophysiology. Arch Med Sci 2006; 2: 146-58.
61. Erkan Ustün M, Md AD, Oztin Ogün C, Sümer F, Gürbilek M. Effects of deferoxamine on tissue superoxide dismutase and glutathione peroxidase levels in experimental head trauma. J Trauma 2001; 51: 22-5.
62. Ustün ME, Duman A, Ogun CO, Vatansev H, Ak A. Effects of nimodipine and magnesium sulfate on endogenous antioxidant levels in brain tissue after experimental head trauma. J Neurosurg Anesthesiol 2001; 13: 227-32.
63. Fan P, Yamauchi T, Noble LJ, Ferriero DM. Age-dependent differences in glutathione peroxidase activity after traumatic brain injury. J Neurotrauma 2003; 20: 437-45.
64. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences. J Cereb Blood Flow Metab 2004; 24: 133-50.
65. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function and inhibition. Biochem J 2001; 357: 593-615.
66. Mesenge C, Verrecchia C, Allix M, Boulu RR, Plotkine M. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J Neurotrauma 1996; 13: 209-14.
67. Wada K, Chatzipanteli K, Busto R, Dietrich WD. Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg 1998; 89: 807-18.
68. Sinz EH, Kochanek PM, Dixon CE, et al. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest 1999; 104: 647-56.
69. Jones NC, Constantin D, Gibson CL, et al. A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury. J Neuropathol Exp Neurol 2004; 63: 708-20.
70. Hille R, Nishino T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995; 9: 995-1003.
71. Kanemitsu H, Tamura A, Kirino T, et al. Allopurinol inhibits uric acid accumulation in the rat brain following focal cerebral ischemia. Brain Res 1989; 499: 367-70.
72. Itoh T, Kawakami M, Yamauchi Y, Shimizu S, Nakamura M. Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke 1986; 17: 1284-7.
73. Diaz-Ruiz A, Rios C, Duarte I, et al. Lipid peroxidation inhibition in spinal cord injury: Cyclosporin-A vs methylprednisolone. Neuroreport 2000; 11: 1765-7.
74. Qian H, Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem Res 1997; 22: 1231-6.
75. Kobeissy FH, Ottens AK, Zhang Z, et al. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics 2006; 5: 1887-98.
76. Keane RW, Kraydieh S, Lotocki G, et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 2001; 60: 422-9.
77. Sakurai M, Nagata T, Abe K, Horinouchi T, Itoyama Y, Tabayashi K. Survival and death-promoting events after transient spinal cord ischemia in rabbits: Induction of Akt and caspase 3 in motor neurons. J Thorac Cardiovasc Surg 2003; 125: 370-7.
78. Dolgun H, Sekerci Z, Turkoglu E, et al. Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits. J Clin Neurosci 2010; 17: 486-9.